MedPath

海南先声药业有限公司

Ownership
-
Established
1993-04-28
Employees
-
Market Cap
-
Website
http://www.simcere.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

181

NMPA:181

Drug Approvals

Trilaciclib Hydrochloride for Injection

Product Name
注射用盐酸曲拉西利
Approval Number
国药准字H20247315
Approval Date
Dec 11, 2024
NMPA

Edaravone and Dexborneol Sublingual Tablets

Product Name
依达拉奉右莰醇舌下片
Approval Number
国药准字H20240041
Approval Date
Dec 1, 2024
NMPA

Ritonavir Tablets

Product Name
利托那韦片
Approval Number
国药准字H20244017
Approval Date
Jul 23, 2024
NMPA

Potassium Sodium Dehydroan drographolide Succinate

Product Name
炎琥宁
Approval Number
国药准字H20065041
Approval Date
Jul 4, 2024
NMPA

Cefteram Pivoxil Tablets

Product Name
头孢特仑新戊酯片
Approval Number
国药准字H20065423
Approval Date
Jul 4, 2024
NMPA

Ondansetron Hydrochloride

Product Name
盐酸昂丹司琼
Approval Number
国药准字H20066066
Approval Date
Jun 27, 2024
NMPA

Valacyclovir Hydrochloride

Product Name
盐酸伐昔洛韦
Approval Number
国药准字H20064078
Approval Date
Jun 27, 2024
NMPA

Cefteram pivoxil

Product Name
头孢特仑新戊酯
Approval Number
国药准字H20045292
Approval Date
Jun 25, 2024
NMPA

Naftopidil

Product Name
萘哌地尔
Approval Number
国药准字H20030547
Approval Date
Jun 25, 2024
NMPA

Meloxicam

Product Name
美洛昔康
Approval Number
国药准字H20030485
Approval Date
Jun 25, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 19
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.